Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas

NCT03161054 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Aggressive Non-Hodgkin Lymphoma

Interventions

DRUG: Prednisone
DRUG: Vinorelbine
DRUG: Etoposide
DRUG: Cyclophosphamide
DRUG: Rituximab

Sponsor

Fondazione Italiana Linfomi - ETS